Januvia licenced for triple therapy

Januvia (sitagliptin) has had its licence extended to include use in triple therapy alongside metformin and a sulfonylurea or a glitazone in type II diabetes inadequately controlled by dual therapy.

The dosage of metformin and glitazone should be maintained and the Januvia dose administered concomitantly.

If it is used in combination with a sulfonylurea, the dose of sulfonylurea may need to be lowered to reduce the risk of hypoglycaemia. The recommended dose of Januvia is 100mg once daily.

View Januvia drug record

Further information: MSD

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Added: Efracea.
Use our constantly updated shortages...

Potentially addictive medicines 'being prescribed for years'

Potentially addictive medicines 'being prescribed for years'

Hundreds of thousands of people are receiving prescriptions...

Calcium and Vitamin D Supplements for Osteoporosis

Calcium and Vitamin D Supplements for Osteoporosis

Formulations, doses and costs of osteoporosis supplements.

High-dose statins could be made available over the counter, says NHS England

High-dose statins could be made available over the counter, says NHS England

High-dose statins could be supplied by pharmacists...